Bovine rotavirus is one of the main pathogens that cause viral diarrhea in calves. It has the characteristics of complex genotype, wide spread, high fatality rate, and interspecies transmission. Bovine rotavirus vaccine can effectively reduce viral diarrhea in calves.

The global Bovine Rotavirus Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Bovine Rotavirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bovine Rotavirus Vaccine.

Report Scope

The Bovine Rotavirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Bovine Rotavirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Bovine Rotavirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Bovine Rotavirus Vaccine Market Report

Report Metric	Details
Report Name	Bovine Rotavirus Vaccine Market
CAGR	5%
Segment by Type	Attenuated Vaccine Inactivated Vaccine
Segment by Application	Calf Adult Cow
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Zoetis, MSD Animal Health, GSK, Boehringer-Ingelheim, Serum Institute of India, Merck Animal Health, Elanco Animal Health, Pharmgal Bio, Creative Biolabs, Lanzhou Institute of Biological Products, Weike Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bovine Rotavirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bovine Rotavirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Bovine Rotavirus Vaccine Market report?

Ans: The main players in the Bovine Rotavirus Vaccine Market are Zoetis, MSD Animal Health, GSK, Boehringer-Ingelheim, Serum Institute of India, Merck Animal Health, Elanco Animal Health, Pharmgal Bio, Creative Biolabs, Lanzhou Institute of Biological Products, Weike Biotechnology

What are the Application segmentation covered in the Bovine Rotavirus Vaccine Market report?

Ans: The Applications covered in the Bovine Rotavirus Vaccine Market report are Calf, Adult Cow

What are the Type segmentation covered in the Bovine Rotavirus Vaccine Market report?

Ans: The Types covered in the Bovine Rotavirus Vaccine Market report are Attenuated Vaccine, Inactivated Vaccine

1 Bovine Rotavirus Vaccine Market Overview

1.1 Product Overview and Scope of Bovine Rotavirus Vaccine

1.2 Bovine Rotavirus Vaccine Segment by Type

1.2.1 Global Bovine Rotavirus Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Attenuated Vaccine

1.2.3 Inactivated Vaccine

1.3 Bovine Rotavirus Vaccine Segment by Application

1.3.1 Global Bovine Rotavirus Vaccine Market Value by Application: (2024-2030)

1.3.2 Calf

1.3.3 Adult Cow

1.4 Global Bovine Rotavirus Vaccine Market Size Estimates and Forecasts

1.4.1 Global Bovine Rotavirus Vaccine Revenue 2019-2030

1.4.2 Global Bovine Rotavirus Vaccine Sales 2019-2030

1.4.3 Global Bovine Rotavirus Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Bovine Rotavirus Vaccine Market Competition by Manufacturers

2.1 Global Bovine Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Bovine Rotavirus Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Bovine Rotavirus Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Bovine Rotavirus Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Bovine Rotavirus Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Bovine Rotavirus Vaccine, Product Type & Application

2.7 Bovine Rotavirus Vaccine Market Competitive Situation and Trends

2.7.1 Bovine Rotavirus Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Bovine Rotavirus Vaccine Players Market Share by Revenue

2.7.3 Global Bovine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Bovine Rotavirus Vaccine Retrospective Market Scenario by Region

3.1 Global Bovine Rotavirus Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Bovine Rotavirus Vaccine Global Bovine Rotavirus Vaccine Sales by Region: 2019-2030

3.2.1 Global Bovine Rotavirus Vaccine Sales by Region: 2019-2024

3.2.2 Global Bovine Rotavirus Vaccine Sales by Region: 2025-2030

3.3 Global Bovine Rotavirus Vaccine Global Bovine Rotavirus Vaccine Revenue by Region: 2019-2030

3.3.1 Global Bovine Rotavirus Vaccine Revenue by Region: 2019-2024

3.3.2 Global Bovine Rotavirus Vaccine Revenue by Region: 2025-2030

3.4 North America Bovine Rotavirus Vaccine Market Facts & Figures by Country

3.4.1 North America Bovine Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Bovine Rotavirus Vaccine Sales by Country (2019-2030)

3.4.3 North America Bovine Rotavirus Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Bovine Rotavirus Vaccine Market Facts & Figures by Country

3.5.1 Europe Bovine Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Bovine Rotavirus Vaccine Sales by Country (2019-2030)

3.5.3 Europe Bovine Rotavirus Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Bovine Rotavirus Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Bovine Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Bovine Rotavirus Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Bovine Rotavirus Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Bovine Rotavirus Vaccine Market Facts & Figures by Country

3.7.1 Latin America Bovine Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Bovine Rotavirus Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Bovine Rotavirus Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Bovine Rotavirus Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Bovine Rotavirus Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Bovine Rotavirus Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Bovine Rotavirus Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Bovine Rotavirus Vaccine Sales by Type (2019-2030)

4.1.1 Global Bovine Rotavirus Vaccine Sales by Type (2019-2024)

4.1.2 Global Bovine Rotavirus Vaccine Sales by Type (2025-2030)

4.1.3 Global Bovine Rotavirus Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Bovine Rotavirus Vaccine Revenue by Type (2019-2030)

4.2.1 Global Bovine Rotavirus Vaccine Revenue by Type (2019-2024)

4.2.2 Global Bovine Rotavirus Vaccine Revenue by Type (2025-2030)

4.2.3 Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Bovine Rotavirus Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Bovine Rotavirus Vaccine Sales by Application (2019-2030)

5.1.1 Global Bovine Rotavirus Vaccine Sales by Application (2019-2024)

5.1.2 Global Bovine Rotavirus Vaccine Sales by Application (2025-2030)

5.1.3 Global Bovine Rotavirus Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Bovine Rotavirus Vaccine Revenue by Application (2019-2030)

5.2.1 Global Bovine Rotavirus Vaccine Revenue by Application (2019-2024)

5.2.2 Global Bovine Rotavirus Vaccine Revenue by Application (2025-2030)

5.2.3 Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Bovine Rotavirus Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Zoetis

6.1.1 Zoetis Corporation Information

6.1.2 Zoetis Description and Business Overview

6.1.3 Zoetis Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Zoetis Bovine Rotavirus Vaccine Product Portfolio

6.1.5 Zoetis Recent Developments/Updates

6.2 MSD Animal Health

6.2.1 MSD Animal Health Corporation Information

6.2.2 MSD Animal Health Description and Business Overview

6.2.3 MSD Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 MSD Animal Health Bovine Rotavirus Vaccine Product Portfolio

6.2.5 MSD Animal Health Recent Developments/Updates

6.3 GSK

6.3.1 GSK Corporation Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 GSK Bovine Rotavirus Vaccine Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Boehringer-Ingelheim

6.4.1 Boehringer-Ingelheim Corporation Information

6.4.2 Boehringer-Ingelheim Description and Business Overview

6.4.3 Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolio

6.4.5 Boehringer-Ingelheim Recent Developments/Updates

6.5 Serum Institute of India

6.5.1 Serum Institute of India Corporation Information

6.5.2 Serum Institute of India Description and Business Overview

6.5.3 Serum Institute of India Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Serum Institute of India Bovine Rotavirus Vaccine Product Portfolio

6.5.5 Serum Institute of India Recent Developments/Updates

6.6 Merck Animal Health

6.6.1 Merck Animal Health Corporation Information

6.6.2 Merck Animal Health Description and Business Overview

6.6.3 Merck Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Merck Animal Health Bovine Rotavirus Vaccine Product Portfolio

6.6.5 Merck Animal Health Recent Developments/Updates

6.7 Elanco Animal Health

6.6.1 Elanco Animal Health Corporation Information

6.6.2 Elanco Animal Health Description and Business Overview

6.6.3 Elanco Animal Health Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolio

6.7.5 Elanco Animal Health Recent Developments/Updates

6.8 Pharmgal Bio

6.8.1 Pharmgal Bio Corporation Information

6.8.2 Pharmgal Bio Description and Business Overview

6.8.3 Pharmgal Bio Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolio

6.8.5 Pharmgal Bio Recent Developments/Updates

6.9 Creative Biolabs

6.9.1 Creative Biolabs Corporation Information

6.9.2 Creative Biolabs Description and Business Overview

6.9.3 Creative Biolabs Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Creative Biolabs Bovine Rotavirus Vaccine Product Portfolio

6.9.5 Creative Biolabs Recent Developments/Updates

6.10 Lanzhou Institute of Biological Products

6.10.1 Lanzhou Institute of Biological Products Corporation Information

6.10.2 Lanzhou Institute of Biological Products Description and Business Overview

6.10.3 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolio

6.10.5 Lanzhou Institute of Biological Products Recent Developments/Updates

6.11 Weike Biotechnology

6.11.1 Weike Biotechnology Corporation Information

6.11.2 Weike Biotechnology Bovine Rotavirus Vaccine Description and Business Overview

6.11.3 Weike Biotechnology Bovine Rotavirus Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolio

6.11.5 Weike Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Bovine Rotavirus Vaccine Industry Chain Analysis

7.2 Bovine Rotavirus Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Bovine Rotavirus Vaccine Production Mode & Process

7.4 Bovine Rotavirus Vaccine Sales and Marketing

7.4.1 Bovine Rotavirus Vaccine Sales Channels

7.4.2 Bovine Rotavirus Vaccine Distributors

7.5 Bovine Rotavirus Vaccine Customers

8 Bovine Rotavirus Vaccine Market Dynamics

8.1 Bovine Rotavirus Vaccine Industry Trends

8.2 Bovine Rotavirus Vaccine Market Drivers

8.3 Bovine Rotavirus Vaccine Market Challenges

8.4 Bovine Rotavirus Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Serum Institute of India

Merck Animal Health

Elanco Animal Health

Creative-Biolabs

Lanzhou Institute of Biological Products

Pharmgal Bio

Weike Biotechnology

List of Tables

Table 1. Global Bovine Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Bovine Rotavirus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Bovine Rotavirus Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Bovine Rotavirus Vaccine Sales (K Doses) of Key Manufacturers (2019-2024)

Table 5. Global Bovine Rotavirus Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Bovine Rotavirus Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Bovine Rotavirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Bovine Rotavirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Bovine Rotavirus Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Bovine Rotavirus Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Bovine Rotavirus Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Bovine Rotavirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bovine Rotavirus Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Bovine Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Bovine Rotavirus Vaccine Sales by Region (2019-2024) & (K Doses)

Table 18. Global Bovine Rotavirus Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Bovine Rotavirus Vaccine Sales by Region (2025-2030) & (K Doses)

Table 20. Global Bovine Rotavirus Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Bovine Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Bovine Rotavirus Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Bovine Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Bovine Rotavirus Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Bovine Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Bovine Rotavirus Vaccine Sales by Country (2019-2024) & (K Doses)

Table 27. North America Bovine Rotavirus Vaccine Sales by Country (2025-2030) & (K Doses)

Table 28. North America Bovine Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Bovine Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Bovine Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Bovine Rotavirus Vaccine Sales by Country (2019-2024) & (K Doses)

Table 32. Europe Bovine Rotavirus Vaccine Sales by Country (2025-2030) & (K Doses)

Table 33. Europe Bovine Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Bovine Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Bovine Rotavirus Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Bovine Rotavirus Vaccine Sales by Region (2019-2024) & (K Doses)

Table 37. Asia Pacific Bovine Rotavirus Vaccine Sales by Region (2025-2030) & (K Doses)

Table 38. Asia Pacific Bovine Rotavirus Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Bovine Rotavirus Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Bovine Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Bovine Rotavirus Vaccine Sales by Country (2019-2024) & (K Doses)

Table 42. Latin America Bovine Rotavirus Vaccine Sales by Country (2025-2030) & (K Doses)

Table 43. Latin America Bovine Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Bovine Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2019-2024) & (K Doses)

Table 47. Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2025-2030) & (K Doses)

Table 48. Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Bovine Rotavirus Vaccine Sales (K Doses) by Type (2019-2024)

Table 51. Global Bovine Rotavirus Vaccine Sales (K Doses) by Type (2025-2030)

Table 52. Global Bovine Rotavirus Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Bovine Rotavirus Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Bovine Rotavirus Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Type (2019-2024)

Table 59. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Type (2025-2030)

Table 60. Global Bovine Rotavirus Vaccine Sales (K Doses) by Application (2019-2024)

Table 61. Global Bovine Rotavirus Vaccine Sales (K Doses) by Application (2025-2030)

Table 62. Global Bovine Rotavirus Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Bovine Rotavirus Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Bovine Rotavirus Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Bovine Rotavirus Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Application (2019-2024)

Table 69. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Application (2025-2030)

Table 70. Zoetis Corporation Information

Table 71. Zoetis Description and Business Overview

Table 72. Zoetis Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 73. Zoetis Bovine Rotavirus Vaccine Product

Table 74. Zoetis Recent Developments/Updates

Table 75. MSD Animal Health Corporation Information

Table 76. MSD Animal Health Description and Business Overview

Table 77. MSD Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 78. MSD Animal Health Bovine Rotavirus Vaccine Product

Table 79. MSD Animal Health Recent Developments/Updates

Table 80. GSK Corporation Information

Table 81. GSK Description and Business Overview

Table 82. GSK Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 83. GSK Bovine Rotavirus Vaccine Product

Table 84. GSK Recent Developments/Updates

Table 85. Boehringer-Ingelheim Corporation Information

Table 86. Boehringer-Ingelheim Description and Business Overview

Table 87. Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 88. Boehringer-Ingelheim Bovine Rotavirus Vaccine Product

Table 89. Boehringer-Ingelheim Recent Developments/Updates

Table 90. Serum Institute of India Corporation Information

Table 91. Serum Institute of India Description and Business Overview

Table 92. Serum Institute of India Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 93. Serum Institute of India Bovine Rotavirus Vaccine Product

Table 94. Serum Institute of India Recent Developments/Updates

Table 95. Merck Animal Health Corporation Information

Table 96. Merck Animal Health Description and Business Overview

Table 97. Merck Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 98. Merck Animal Health Bovine Rotavirus Vaccine Product

Table 99. Merck Animal Health Recent Developments/Updates

Table 100. Elanco Animal Health Corporation Information

Table 101. Elanco Animal Health Description and Business Overview

Table 102. Elanco Animal Health Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 103. Elanco Animal Health Bovine Rotavirus Vaccine Product

Table 104. Elanco Animal Health Recent Developments/Updates

Table 105. Pharmgal Bio Corporation Information

Table 106. Pharmgal Bio Description and Business Overview

Table 107. Pharmgal Bio Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 108. Pharmgal Bio Bovine Rotavirus Vaccine Product

Table 109. Pharmgal Bio Recent Developments/Updates

Table 110. Creative Biolabs Corporation Information

Table 111. Creative Biolabs Description and Business Overview

Table 112. Creative Biolabs Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 113. Creative Biolabs Bovine Rotavirus Vaccine Product

Table 114. Creative Biolabs Recent Developments/Updates

Table 115. Lanzhou Institute of Biological Products Corporation Information

Table 116. Lanzhou Institute of Biological Products Description and Business Overview

Table 117. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 118. Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product

Table 119. Lanzhou Institute of Biological Products Recent Developments/Updates

Table 120. Weike Biotechnology Corporation Information

Table 121. Weike Biotechnology Description and Business Overview

Table 122. Weike Biotechnology Bovine Rotavirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)

Table 123. Weike Biotechnology Bovine Rotavirus Vaccine Product

Table 124. Weike Biotechnology Recent Developments/Updates

Table 125. Key Raw Materials Lists

Table 126. Raw Materials Key Suppliers Lists

Table 127. Bovine Rotavirus Vaccine Distributors List

Table 128. Bovine Rotavirus Vaccine Customers List

Table 129. Bovine Rotavirus Vaccine Market Trends

Table 130. Bovine Rotavirus Vaccine Market Drivers

Table 131. Bovine Rotavirus Vaccine Market Challenges

Table 132. Bovine Rotavirus Vaccine Market Restraints

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Bovine Rotavirus Vaccine

Figure 2. Global Bovine Rotavirus Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Bovine Rotavirus Vaccine Market Share by Type in 2023 & 2030

Figure 4. Attenuated Vaccine Product Picture

Figure 5. Inactivated Vaccine Product Picture

Figure 6. Global Bovine Rotavirus Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Bovine Rotavirus Vaccine Market Share by Application in 2023 & 2030

Figure 8. Calf

Figure 9. Adult Cow

Figure 10. Global Bovine Rotavirus Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 11. Global Bovine Rotavirus Vaccine Market Size (2019-2030) & (US$ Million)

Figure 12. Global Bovine Rotavirus Vaccine Sales (2019-2030) & (K Doses)

Figure 13. Global Bovine Rotavirus Vaccine Average Price (US$/Dose) & (2019-2030)

Figure 14. Bovine Rotavirus Vaccine Report Years Considered

Figure 15. Bovine Rotavirus Vaccine Sales Share by Manufacturers in 2023

Figure 16. Global Bovine Rotavirus Vaccine Revenue Share by Manufacturers in 2023

Figure 17. The Global 5 and 10 Largest Bovine Rotavirus Vaccine Players: Market Share by Revenue in 2023

Figure 18. Bovine Rotavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 19. Global Bovine Rotavirus Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 20. North America Bovine Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 21. North America Bovine Rotavirus Vaccine Revenue Market Share by Country (2019-2030)

Figure 22. United States Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 23. Canada Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 24. Europe Bovine Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 25. Europe Bovine Rotavirus Vaccine Revenue Market Share by Country (2019-2030)

Figure 26. Germany Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. France Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. U.K. Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. Italy Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. Russia Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Asia Pacific Bovine Rotavirus Vaccine Sales Market Share by Region (2019-2030)

Figure 32. Asia Pacific Bovine Rotavirus Vaccine Revenue Market Share by Region (2019-2030)

Figure 33. China Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Japan Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. South Korea Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. India Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Australia Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. China Taiwan Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Southeast Asia Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Latin America Bovine Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 41. Latin America Bovine Rotavirus Vaccine Revenue Market Share by Country (2019-2030)

Figure 42. Mexico Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Brazil Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Argentina Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Bovine Rotavirus Vaccine Sales Market Share by Country (2019-2030)

Figure 46. Middle East & Africa Bovine Rotavirus Vaccine Revenue Market Share by Country (2019-2030)

Figure 47. Turkey Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. UAE Bovine Rotavirus Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Global Sales Market Share of Bovine Rotavirus Vaccine by Type (2019-2030)

Figure 51. Global Revenue Market Share of Bovine Rotavirus Vaccine by Type (2019-2030)

Figure 52. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Type (2019-2030)

Figure 53. Global Sales Market Share of Bovine Rotavirus Vaccine by Application (2019-2030)

Figure 54. Global Revenue Market Share of Bovine Rotavirus Vaccine by Application (2019-2030)

Figure 55. Global Bovine Rotavirus Vaccine Price (US$/Dose) by Application (2019-2030)

Figure 56. Bovine Rotavirus Vaccine Value Chain

Figure 57. Bovine Rotavirus Vaccine Production Process

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Distributors Profiles

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions